CELG

How to Play 62 Stock Upgrades and Downgrades Today

During these times, it pays to stay on top of the latest profit opportunities. Today's blog post highlights 62 stocks to buy, sell, or hold. More 

Watch Powerhouse Biotech’s Mesoblast IPO Closely

Investors, get ready: Australian stem cell biotech, Mesoblast, has filed with the SEC to raise up to $70 million in its IPO. It's a steal. More 

Here’s Why You Should Buy More CELG Shares After Earnings Dip

Third quarter show that CELG continues to grow its business, it continues to make product people like and that Revlimid hasn't peaked yet. More 

5 Biotech Stocks to Buy for a Q4 Rally

Biotech stocks have been a consistent area of weakness, but things are turning around for the battered sector. More 

7 Corporate Tax Dodgers Paying Less Than 15% Rates

Whatever you think about government spending, the cash has to come from somewhere -- and these corporate tax dodgers aren't paying their share. More 

GILD Stock: What Investors Really Want to See From Q3

Gilead Science's Q3 numbers aren't as important to GILD stock compared to what it does to solidify the future. More 

3 Undervalued Biotech Stocks To Buy

Despite the sharp correction in the heath care sector, these three biotech stocks should recover off of their strong fundamentals. More